BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 23784082)

  • 1. Activation of NF-κB by SOD2 promotes the aggressiveness of lung adenocarcinoma by modulating NKX2-1-mediated IKKβ expression.
    Chen PM; Wu TC; Wang YC; Cheng YW; Sheu GT; Chen CY; Lee H
    Carcinogenesis; 2013 Nov; 34(11):2655-63. PubMed ID: 23784082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NKX2-1-mediated p53 expression modulates lung adenocarcinoma progression via modulating IKKβ/NF-κB activation.
    Chen PM; Wu TC; Cheng YW; Chen CY; Lee H
    Oncotarget; 2015 Jun; 6(16):14274-89. PubMed ID: 25881545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation of miR-138 sustains NF-κB activation and promotes lipid raft formation in esophageal squamous cell carcinoma.
    Gong H; Song L; Lin C; Liu A; Lin X; Wu J; Li M; Li J
    Clin Cancer Res; 2013 Mar; 19(5):1083-93. PubMed ID: 23319823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytoplasmic Ape1 expression elevated by p53 aberration may predict survival and relapse in resected non-small cell lung cancer.
    Wu HH; Chu YC; Wang L; Tsai LH; Lee MC; Chen CY; Shieh SH; Cheng YW; Lee H
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S336-47. PubMed ID: 22688662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LKB1 loss by alteration of the NKX2-1/p53 pathway promotes tumor malignancy and predicts poor survival and relapse in lung adenocarcinomas.
    Tsai LH; Chen PM; Cheng YW; Chen CY; Sheu GT; Wu TC; Lee H
    Oncogene; 2014 Jul; 33(29):3851-60. PubMed ID: 23995788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MnSOD overexpression confers cisplatin resistance in lung adenocarcinoma via the NF-κB/Snail/Bcl-2 pathway.
    Chen PM; Cheng YW; Wu TC; Chen CY; Lee H
    Free Radic Biol Med; 2015 Feb; 79():127-37. PubMed ID: 25499851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncoprotein E7 from beta human papillomavirus 38 induces formation of an inhibitory complex for a subset of p53-regulated promoters.
    Saidj D; Cros MP; Hernandez-Vargas H; Guarino F; Sylla BS; Tommasino M; Accardi R
    J Virol; 2013 Nov; 87(22):12139-50. PubMed ID: 24006445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential regulation of RANTES and IL-8 expression in lung adenocarcinoma cells.
    Henriquet C; Gougat C; Combes A; Lazennec G; Mathieu M
    Lung Cancer; 2007 May; 56(2):167-74. PubMed ID: 17207890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LATS2 inhibits the activity of NF-κ B signaling by disrupting the interaction between TAK1 and IKKβ.
    Yao F; Zhou W; Zhong C; Fang W
    Tumour Biol; 2015 Sep; 36(10):7873-9. PubMed ID: 25946971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. KINK-1, a novel small-molecule inhibitor of IKKbeta, and the susceptibility of melanoma cells to antitumoral treatment.
    Schön M; Wienrich BG; Kneitz S; Sennefelder H; Amschler K; Vöhringer V; Weber O; Stiewe T; Ziegelbauer K; Schön MP
    J Natl Cancer Inst; 2008 Jun; 100(12):862-75. PubMed ID: 18544741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. hRAD9 functions as a tumor suppressor by inducing p21-dependent senescence and suppressing epithelial-mesenchymal transition through inhibition of Slug transcription.
    Wen FC; Chang TW; Tseng YL; Lee JC; Chang MC
    Carcinogenesis; 2014 Jul; 35(7):1481-90. PubMed ID: 24403312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nkx2.1 transcription factor in lung cells and a transforming growth factor-beta1 heterozygous mouse model of lung carcinogenesis.
    Kang Y; Hebron H; Ozbun L; Mariano J; Minoo P; Jakowlew SB
    Mol Carcinog; 2004 Aug; 40(4):212-31. PubMed ID: 15264213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-503 targets PI3K p85 and IKK-β and suppresses progression of non-small cell lung cancer.
    Yang Y; Liu L; Zhang Y; Guan H; Wu J; Zhu X; Yuan J; Li M
    Int J Cancer; 2014 Oct; 135(7):1531-42. PubMed ID: 24550137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enterovirus 71 2C protein inhibits TNF-α-mediated activation of NF-κB by suppressing IκB kinase β phosphorylation.
    Zheng Z; Li H; Zhang Z; Meng J; Mao D; Bai B; Lu B; Mao P; Hu Q; Wang H
    J Immunol; 2011 Sep; 187(5):2202-12. PubMed ID: 21810613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolyl hydroxylase-3 is down-regulated in colorectal cancer cells and inhibits IKKbeta independent of hydroxylase activity.
    Xue J; Li X; Jiao S; Wei Y; Wu G; Fang J
    Gastroenterology; 2010 Feb; 138(2):606-15. PubMed ID: 19786027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-451 inhibits cell proliferation in human hepatocellular carcinoma through direct suppression of IKK-β.
    Li HP; Zeng XC; Zhang B; Long JT; Zhou B; Tan GS; Zeng WX; Chen W; Yang JY
    Carcinogenesis; 2013 Nov; 34(11):2443-51. PubMed ID: 23740840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of NF-kappaB signaling by inhibitor of NF-kappaB kinase beta increases aggressiveness of ovarian cancer.
    Hernandez L; Hsu SC; Davidson B; Birrer MJ; Kohn EC; Annunziata CM
    Cancer Res; 2010 May; 70(10):4005-14. PubMed ID: 20424119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Nuclear factor-kappaB activity and its correlation with cell proliferation in non-small cell lung cancer tissues].
    Zhang J; Xu YJ; Zhang ZX; DU CL; Qiao LF; Ni W; Chen SX
    Zhonghua Jie He He Hu Xi Za Zhi; 2007 Oct; 30(10):771-5. PubMed ID: 18218209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NF-kappaB activates transcription of the RNA-binding factor HuR, via PI3K-AKT signaling, to promote gastric tumorigenesis.
    Kang MJ; Ryu BK; Lee MG; Han J; Lee JH; Ha TK; Byun DS; Chae KS; Lee BH; Chun HS; Lee KY; Kim HJ; Chi SG
    Gastroenterology; 2008 Dec; 135(6):2030-42, 2042.e1-3. PubMed ID: 18824170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic silencing of Aristaless-like homeobox-4, a potential tumor suppressor gene associated with lung cancer.
    Liu WB; Han F; Du XH; Jiang X; Li YH; Liu Y; Chen HQ; Ao L; Cui ZH; Cao J; Liu JY
    Int J Cancer; 2014 Mar; 134(6):1311-22. PubMed ID: 24037716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.